Brief: Myriad Genetics Q2 Revenue USD 190.7 Million Vs. IBES Estimate USD 206 Million
30/07/2026 21:06
BRIEF-Myriad Genetics Q2 Revenue USD 190.7 Million Vs. IBES Estimate USD 206 Million Jul 30 (Reuters) - Myriad Genetics Q2 gross margin 66.6%.
- Q2 adjusted operating expenses USD 150.5 million
- Q2 operating expenses USD 165.9 million
- Q2 operating income USD -38.9 million
Recent news on Myriad Genetics
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple